Curcumin is a phytochemical isolated from Curcuma longa with potent tumor‐suppressor
activity, which has shown significant efficacy in pre‐clinical and clinical studies. Curcumin …

The advancement in therapy has provided a dramatic improvement in the rate of recovery
among cancer patients. However, this improved survival is also associated with enhanced …

Background Cisplatin-induced cardiotoxicity severely limits its clinical application as an
antitumor drug and increases the risk of cardiovascular disease. Icariin (ICA), the main …

Cisplatin (CP) is used to treat a wide range of tumors and kills cells (anti-neoplastic drug)
through different mechanisms, including, formation of reactive oxygen species (ROS), DNA …

Cancer patients undergoing radiotherapy, chemotherapy, or targeted cancer therapy are
exposed to the risk of several side effects because of the heavy production of ROS by …

Breast cancer is the most common malignancy affecting females worldwide and is also
among the top causes of all cancer-related deaths. Cardiovascular disease (CVD) is known …

Metabolic reprogramming is a common hallmark of cancer cells. Cancer cells exhibit
metabolic flexibility to maintain high proliferation and survival rates. In other words …

Innovative therapeutic strategies in childhood cancer led to a significant reduction in cancer-
related mortality. Cancer survivors are a growing fragile population, at risk of long-term side …

Myocardial injury influenced by cisplatin (Cis) is a compelling reason to hunt out a treatment
modality to overcome such a threat in cisplatin-treated patients. Breast Milk mesenchymal …

Propionic acid (PRA) is a metabolic end-product of enteric bacteria in the gut, and it is
commonly used as a food preservative. Despite the necessity of PRA for immunity in the …